Topic · page 109 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 4,321–4,360 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

BMJ Open Diabetes Res Care8 Mar 2023
Diabetes and infectious disease mortality in Mexico City
Cohort study
Diabetes Obes Metab8 Mar 2023
Use of the FreeStyle Libre system and diabetes treatment progression in T2DM : Results from a retrospective cohort study using a Canadian private payer claims database
Cohort study
Diabetes Res Clin Pract7 Mar 2023
Determinants of blood glucose concentrations following a high carbohydrate meal in type 2 diabetes: A multiple linear regression analysis
Cross-sectional study
Cardiovasc Diabetol7 Mar 2023
Myocardial fat accumulation is associated with cardiac dysfunction in patients with type 2 diabetes, especially in elderly or female patients: a retrospective observational study
Cohort study
Clin Endocrinol (Oxf)7 Mar 2023
The GLP‐1 receptor agonist exenatide reduces serum TSH by its effect on body weight in people with type 2 diabetes
Cohort study
Diabetes Obes Metab7 Mar 2023
The importance of targeting multiple risk markers in patients with type 2 diabetes: A post‐hoc study from the CANVAS programme
Secondary analysis
Diabetes Obes Metab7 Mar 2023
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study
Cohort study
Diabetes Obes Metab6 Mar 2023
Cardiovascular outcomes trial data from EMPA‐REG OUTCOME , CAROLINA and CARMELINA : Assessment of a novel staging system for type 2 diabetes
Secondary analysis
J Clin Endocrinol Metab6 Mar 2023
Evaluation of Stress Response in Middle-Aged Male Diabetic Hypertensive Patients
Research article
Diabetes Res Clin Pract5 Mar 2023
Efficacy and safety of oral semaglutide in type 2 diabetes mellitus: A systematic review and meta-analysis
Meta-analysis
Cardiovasc Diabetol4 Mar 2023
The joint association of diabetes status and NT-ProBNP with adverse cardiac outcomes in patients with non-ST-segment elevation acute coronary syndrome: a prospective cohort study
Cohort study
Lancet Diabetes Endocrinol3 Mar 2023
Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial
Secondary analysis
Diabetes Care3 Mar 2023
Incidence of LADA and Type 2 Diabetes in Relation to Tobacco Use and Genetic Susceptibility to Type 2 Diabetes and Related Traits: Findings From a Swedish Case-Control Study and the Norwegian HUNT Study
Meta-analysis
J Clin Endocrinol Metab3 Mar 2023
A Novel In Vitro Assay Correlates Insulin Receptor Autoantibodies With Fasting Insulin in Type B Insulin Resistance
Mechanistic study
J Clin Endocrinol Metab3 Mar 2023
Cancer Outcomes Among Prediabetes and Type 2 Diabetes Populations With Dietary and Physical Activity–based Lifestyle Interventions
Meta-analysis
Diabetes Obes Metab3 Mar 2023
A cross‐sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa ( PACT‐MEA ): Study design and rationale
Trial design
Diabet Med3 Mar 2023
Risk of dementia associated with body mass index, changes in body weight and waist circumference in older people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study
Cohort study
Diabetologia2 Mar 2023
The utility of a type 2 diabetes polygenic score in addition to clinical variables for prediction of type 2 diabetes incidence in birth, youth and adult cohorts in an Indigenous study population
Diagnostic or prognostic study
Diabetes Obes Metab2 Mar 2023
Association between stress hyperglycaemia and in‐hospital cardiac events after coronary artery bypass grafting in patients without diabetes: A retrospective observational study of 5450 patients
Cohort study
Diabetes Care1 Mar 2023
Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients
Mechanistic study
Diabetes Care1 Mar 2023
Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes
Secondary analysis
Cardiovasc Diabetol1 Mar 2023
Prediabetes and all-cause mortality in young patients undergoing coronary artery angiography: a multicenter cohort study in China
Cohort study
Diabetologia1 Mar 2023
Identifying blood biomarkers for type 2 diabetes subtyping: a report from the ORIGIN trial
Secondary analysis
JAMA Intern Med1 Mar 2023
Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA 1c Levels
Cohort study
JAMA Netw Open1 Mar 2023
Development of Osteoarthritis in Adults With Type 2 Diabetes Treated With Metformin vs a Sulfonylurea
Cohort study
JAMA Netw Open1 Mar 2023
Global Prevalence of Diabetic Retinopathy in Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis
Meta-analysis
BMJ Open Diabetes Res Care1 Mar 2023
Mediation of an association between neighborhood socioeconomic environment and type 2 diabetes through the leisure-time physical activity environment in an analysis of three independent samples
Case-control study
JAMA Netw Open1 Mar 2023
Risk of Death Associated With Reversion From Prediabetes to Normoglycemia and the Role of Modifiable Risk Factors
Cohort study
Diabetes Care28 Feb 2023
Ultra-Processed Food Consumption and Risk of Type 2 Diabetes: Three Large Prospective U.S. Cohort Studies
Meta-analysis
Diabetes Obes Metab28 Feb 2023
Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta‐analysis
Meta-analysis
Diabet Med28 Feb 2023
Diagnostic and prognostic biomarkers reflective of cardiac remodelling in diabetes mellitus: A scoping review
Research article
Diabetes Obes Metab28 Feb 2023
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease
Randomized controlled trial
Diabetes Obes Metab28 Feb 2023
iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real‐world study
Cohort study
Diabetes Obes Metab28 Feb 2023
Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study ( SWITCH‐SEMA 1 study)
Randomized controlled trial
J Clin Endocrinol Metab28 Feb 2023
SGLT2 Inhibitors: Effect on Myocardial Infarction and Stroke in Type 2 Diabetes
Meta-analysis
Obesity (Silver Spring)28 Feb 2023
Social jet lag and (changes in) glycemic and metabolic control in people with type 2 diabetes
Cohort study
Obesity (Silver Spring)27 Feb 2023
Sleep duration and timing are prospectively linked with insulin resistance during late adolescence
Cohort study
Diabetes Res Clin Pract27 Feb 2023
Longer time in blood pressure target range improves cardiovascular outcomes among patients with Type 2 diabetes: A secondary analysis of a randomized clinical trial
Secondary analysis
Diabetologia27 Feb 2023
Childhood adiposity and novel subtypes of adult-onset diabetes: a Mendelian randomisation and genome-wide genetic correlation study
Research article
Diabetes Res Clin Pract26 Feb 2023
Annual trends in glycemic control and prescribing patterns in diabetic treatment according to age in Japanese patients with type 2 diabetes between 2012 and 2019 (JDDM 71)
Cross-sectional study

All 4,758 Briefs in ExploreShowing Briefs 4,321–4,360 of 4,758, newest first